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1996). Such values had long been thought to underesti-
mate the size of the eCTL population. The assumption
was that LDA may provide a reasonable measure of the
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*Department of Immunology CD81 memory T cells (mCTL) that can be expanded
through 10 or more rounds of in vitro culture, while fur-St. Jude Children's Research Hospital
Memphis, Tennessee 38105 ther stimulation of the virus-specific eCTLs probably
leads to activation-induced cell death (Iezzi et al., 1998).²Emory Vaccine Center
Department of Microbiology and Immunology For example, in mice primed several months previously
with a parainfluenza type 1 virus (Sendai virus) and thenEmory University School of Medicine
Atlanta, Georgia 30322 challenged intranasally (i.n.) with an influenza A virus,
the influenza-specific CTL precursor (pCTL) frequencies
in the inflammatory cells recovered by bronchoalveolar
lavage (BAL) were only 2- to 3-fold higher than thoseSummary
for the Sendai-specific memory set (Tripp et al., 1995b).
However, such BAL populations contain potent eCTLsVirus-specific CD81 effector T cells (eCTL) are en-
specific for influenza virus but not for Sendai virus.riched in the lungs of mice with primary influenza
The development of new techniques for staining anti-pneumonia, though later detection of memory T cells
gen-specific CD81 T cells with tetrameric complexes of(mCTL) in the mediastinal lymph nodes (MLN) or
MHC class I glycoprotein1peptide, or stimulating T cellsspleen by peptide-based staining protocols is at the
with peptide and then analyzing for the synthesis oflimits of flow cytometric analysis. Respiratory chal-
interferon-g (IFNg), has greatly facilitated the dissectionlenge with an H3N2 virus months after H1N1 priming
of cell-mediated immunity (Altman et al., 1996; Buschinduces a massive recall response, which reduces vi-
et al., 1998; Butz and Bevan, 1998; Murali-Krishna et al.,rus titers 2±3 days earlier than in nave controls. Influ-
1998). Experiments using one or more of these ap-enza-specific mCTL produce interferon-g within 6 hr,
proaches toprobe human peripheral blood lymphocytesbut still take 4±5 days to localize to the infected respi-
from individuals infected with human immunodeficiencyratory tract. The delay reflects that the recall response
virus (HIV) and spleen cells from mice given lymphocyticdevelops first in the MLN, which contains relatively
choriomeningitis virus (LCMV), have shown very clearlyfew mCTL. The response to a subdominant epitope is
that LDA underestimates the prevalence of virus-immuneless obvious after secondary challenge.
CD81 T cells in both acute and persistent infections by
a factor of at least 10-fold (Altman et al., 1996; Butz and
Introduction Bevan, 1998; Murali-Krishna et al., 1998).
The present analysis describes the dual application
The outcome of infection in a previously unexposed of the tetramer-staining and peptide stimulation ap-
individual is generally considered to reflect a race be- proaches to quantitate the primary and secondary CD81
tween the development of cell-mediated immunity and CTL response in mice with influenza pneumonia, being
the rate of virus growth (Doherty et al., 1992). The greater a description of the events occurring in a nonlymphoid
the number of virus-infected cells at the stage when the site of virus-induced pathology. The results establish
virus-specific CD81 cytotoxic T lymphocyte effectors that the influenza-specific CD81 eCTL numbers are
(eCTL) leave the regional lymph nodes and travel via the much greater than previously suspected (Tripp et al.,
blood to thesite(s) of virus replication in somatic tissues, 1995b; Doherty et al., 1996) and illustrate very clearly
the less favorable the clinical outcome is likely to be. the durability, benefits, and limitations of virus-specific
The techniques for measuring both the extent of virus CD81 T cell memory.
replication and the numbers of infected cells are both
extremely sensitive and long established. Until very re-
Resultscently, the same could not be said for the quantitation
of the CD81 CTL response, the other half of the equa-
Specificity of the Tetramer-Staining Reactiontion. Though CD81 T cells recovered from sites of virus-
Tetrameric complexes of H-2Db 1 Sendai virus NP324±332induced pathology show evidence of potent virus-spe-
(SEV9) or H-2Db 1 influenza A virus NP366±374 (NPP) werecific CTL activity (Zinkernagel and Doherty, 1973; Allan
used to stain virus-specifichybridoma T cell lines (Deck-et al., 1990; Hou et al., 1992), it had not been possible
hut et al., 1993; Cole et al., 1997) of the correspondingto determine the actual eCTL numbers.
specificity (Figure 1A). The reactions in both cases wereThe best method available, limiting dilution analysis
specific for the appropriate T cells, showing no signifi-(LDA) utilizing a 5±7 day microculture protocol, generally
cant overlap in the extent of binding. The NPP tetramerindicated that ,1:50 of the extravasated CD81 T cells
was then used to probe the inflammatory lymphocytesare specific for the inducing pathogen (Doherty et al.,
obtained (Allan et al., 1990) by BAL of mice challenged
i.n. 8 days previously with either the HKx31 (H3N2) influ-
enza A virus or with the B/HK influenza B virus that does³To whom correspondence should be addressed (e-mail: peter.
doherty@stjude.org). not contain the NP366±374 epitope (Allan et al., 1993). While
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(H3N2) and the internal components of PR8 (Kilbourne,
1969). The neutralizing antibody response to the surface
H and N glycoproteins of these two viruses is not cross-
reactive, so the magnitude of the secondary antigenic
challenge is, prior to the development of eCTL activity,
in every sense equivalent to that occurring in the primary
response. The top figures in the upper right quadrant
of the flow cytometry profiles shown in Figure 2 give
the percentage of the BAL population that stains for
both CD8 and NPP, those below estimate the numbers
(per mouse) of NPP1CD81 cells in the BAL, while the
bottom value is the SEV9 tetramer-staining control.
Significant numbers of NPP1CD81 T cells were first
detected in theBAL on day 7 in the primary response and
on day 5 after secondary challenge, confirming earlier
impressions from eCTL assays that established T cell
memory confers (at best) a 2±3 day advantage in the
rate of effector T cell development and localization to
the influenza virus±infected respiratory tract (Bennink
et al., 1978). The secondary response has long been
known to be greater in overall magnitude. What could
not, however, be predicted from any previous analysis
was that .15% of the BAL CD81 T cells in the primary
response and .65% in the secondary response were
Figure 1. Specificity of the Staining Reaction with the NPP Tetramer
specific for the immunodominant H-2Db1NP366±374 (Town-(A) The influenza H-2Db1NP366±374-specific and Sendai H-2Db1 send et al., 1986). The numbers of inflammatory CD81NP324±332-specific T cell hybridomas were assayed by flow cytometry
NPP1 T cells present at the peak of the inflammatoryfor staining with either the NPP (bold line) or SEV9 (thin line) tet-
process on day 10 were 5-fold higher in the secondaryramers.
(B) The inflammatory BAL population was obtained from B6 mice 8 response (2 3 105 cf. 1 3 106).
days after i.n. infection with either HKx31 or B/HK influenza A or B Comparable profiles for the localization and accumu-
virus, stained for surface CD8 and the NPP tetramer, and examined lation of NP-specific CD81 T cells to the virus-infected
by flow cytometry. The numbers given show the percentage of BAL
respiratory tract were recorded from the same experi-cells in the lymphocyte/lymphoblast gate falling within the respec-
ment (as in Figure 2) analyzed using the peptide/Brefel-tive quadrants. The proportion of CD81 T cells staining with the NPP
tetramer on day 8 was consistent in five independent experiments. din A/IFNg protocol (Figure 3). Again, the massive
secondary response for CD81IFNg1 lymphocytes is ap-
parent 2 days earlier, and the overall magnitude is about
the percentage of CD81 T cells in the total lymphocyte
5-fold greater than for the primary. More than 60% of
pool obtained by BAL was comparable between the two
the inflammatory CD81 T cells in the challenged mice
infections, approximately 1:8 of the CD81 T cells in the
are IFNg-producing H-2Db1NP366±374-specific eCTL orBAL of the HKx31-primed mice stained with the NPP
the precursors of such eCTL.tetramer. The value for the mice given the B/HK virus
Further sets of experiments confirmed the observa-was ,0.1% (Figure 1B). Other experiments (data not
tions for staining BAL cells with the NPP tetramer and forshown) established that the NPP tetramer does not bind
stimulation with the NP366±374 peptide in mice challengedto CD41 T cells in the BAL of mice infected with the
with the HKx31 virus and also determined the preva-HKx31 virus. Thus, staining with the NPP tetramer is
lence of CD81IFNg1 T cells specific for the minor H-2Kb-very specific, both for a T cell hybridoma maintained in
NS2114±121 epitope (Vitiello et al., 1996) in primary andvitro and for highly activated inflammatory cellsobtained
secondary viral pneumonia (Table 1, BAL columns). Thedirectly from the pneumonic lung.
mice utilized in Table 1 had been immunized with the
PR8 virus 56 days (Expt. 1), 42 days (Expt. 2), or 27 daysQuantitation of Virus-Specific CD81 T Cells
(Expt. 3; Table 1) previously, compared with 240 daysin the Pneumonic Lung
for the group analyzed in Figures 2 and 3. Taking thePreliminary studies (Figure 1B and unpublished data)
results together indicates that the recall response mayindicated that the prevalence of NPP1CD81 T cells in the
be slightly delayed (though still very substantial), withBAL was .10-fold higher than suggested from previous
increasing time following the initial exposure to virusdeterminations of CTLp frequency. The next experiment
(Figure 2 and Table 1) as influenza H-2Db 1 NP366±374-(Figure 2) compared the kinetics of CD81 T cell localiza-
specific CD81 T cells were detected in the BAL as earlytion and retention to the BAL following i.n. HKx31 (H3N2)
as 3 days after challenge in the younger mice (Tablechallenge of immunologically naive mice (Figure 2A, pri-
1, 45 days). Earlier studies indicate that the primarymary) and mice that had been primed 8 months pre-
eCTL response also develops more slowly in older mice,viously by intraperitoneal (i.p.) injection of the A/PR/8/
though there is no obvious age-related difference in34 (PR8, H1N1) virus (Figure 2B, secondary). The HKx31
growth characteristics for the influenza A viruses (Ben-virus is a recombinant that expresses the surface hem-
agglutinin (H) and neuraminidase (N) proteins of A/Aichi der et al., 1995).
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Figure 2. Visualization of CD81NPP1 T Cells
in BAL Population Recovered from Primary
or Secondary Influenza Pneumonia
Naive (A) or PR8-immune (B) mice (primed for
8 months) were infected i.n. with the serologi-
cally distinct HKx31 virus. The BAL popula-
tions collected from each group of mice (n 5
9±10) were pooled and examined by flow cy-
tometry for surface staining with anti-CD8a
andthe NPP tetramer. The percentage of BAL
cells in the lymphocyte/lymphoblast gate is
shown for each of the quadrants. The other
numbers in the upper right-hand gate are an
estimate of the average/mouse counts for the
CD81 NPP1 set and (in brackets) the percent-
age of live BAL cells staining with the SEV9
tetramer.
Response Profiles for the Minor Epitope in the secondary response, while there was no change
in frequency for the NS2-specific set (Table 2, mMTThe numbers of T cells specific for the subdominant
H-2Kb1NS2114±121 epitope were relatively higher in the mice). The same effect was seen for the mediastinal
lymph nodes (MLN) (see Footnote to Table 2). Thus,primary than the secondary response (Table 1, NS2-
IFNg and BAL). Comparing the results following stimula- though the H-2Kb1NS2114±121-specific T cells were de-
tectable in the BAL as early as 5 days after secondarytion with the two peptides indicated that the eCTL
counts for this epitope were at least 33% of those for challenge, they did not show the dramatic expansion in
numbers seen for the H-2Db 1 NP366±374 set.the dominant H-2Db1NP366±374 response on days 7 and
13 in the primary compared with ,6% in the secondary
(Table 1). The greater prominence of minor NS2 epitope Virus-Specific CD81 T Cells in Lymphoid Tissue
Though as many as 10% of the CD81 mCTL in lymphoidin the primary response was confirmed in further experi-
ments with individual mice (Table 2, B6 mice). The num- tissue may be specific for LCMV in the very long term
(Butz and Bevan, 1998; Murali-Krishna et al., 1998), thebers of NP-specific eCTL were significantly increased
following secondary challenge, while this was not the influenza-NP366±374-specific mCTL in MLN and spleen
were at the limits of detection for both peptide-basedcase for the NS2-specific population that remained at
a comparable, or lower, frequency (Table 2). flow cytometry assays within 6 weeks of i.p. priming
(Table 1, days 56 and 42 and MLN and spleen). TheThe HKx31→PR8 challenge experiment (Table 1; Ta-
ble 2, B6 mice) left open the possibility that some differ- CD81 set was enriched prior to counting to facilitate
the FACS analysis by decreasing the number of eventsence between these two viruses might influence the
immunodominance hierarchy. We thus repeated the acquired. The frequencies of H-2Db1NP366±374-specific
mCTL for resting mice ranged from 1:600 to1:1400 whenanalysis using an HKx31 challenge in HKx31-primed
Ig2/2 mMT mice (Kitamura et al., 1991; Topham and Do- corrected to total spleen or MLN lymphocyte counts,
the convention used previously for the LDA studies withherty, 1998), to avoid any possible confounding effect
due to neutralizing antibody. Again, the prevalence of the influenza model (Doherty et al., 1996). This is gener-
ally higher than previous findings for LDA with wholethe NP-specific eCTL in the BAL increased dramatically
Figure 3. Quantitation of the Primary and
Secondary Viral Pneumonia by Short-Term
Stimulation with Peptide and Staining for
IFNg
This analysis utilized the same mice that were
assayed in Figure 2. The BAL cells were incu-
bated for 6 hr in Brefeldin A, the NP366±374 pep-
tide, stained for CD8a, and then permeabil-
ized by fixation and stained for IFNg. The
percentage of BAL cells in the lymphocyte/
lymphoblast gate is shown for the respective
quadrants, together with (brackets) the per-
centage of BAL cells staining for IFNg after
incubation in the absence of NP366±374.
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Table 1. Comparison of Primary and Secondary Influenza-Specific CD81 T Cell Responses in the BAL, MLN, and Spleen
Days After Infectiona CD81 T Cells Staining (%)
PR8 HKx31 NPPb NP-IFNg NS2-IFNgb
i.p. i.n. BAL MLN Spleen BAL MLN Spleen BAL MLN Spleen
Experiment 1
Ð 7 4.7 0.3 0.5 6.7 0.1 0.5 2.8 0.2 0.1
Ð 13 10 1.5 1.2 6.9 0.4 0.4 5.1 0.2 0.2
56 Ð NT 0.3 0.9 NT 0.2 0.6 NT ,0.1 0.1
63 7 81 7.0 24 65 6.8 16 0.8 0.2 0.6
69 13 80 17 39 77 14 21 0.7 0.6 0.3
Experiment 2
Ð 3 ,0.1 ,0.1 ,0.1 1.5 0.2 0.1 ,0.1 0.5 0.1
Ð 5 0.4 ,0.1 ,0.1 0.9 0.4 0.1 1.3 0.7 0.2
Ð 7 3.4 0.1 0.2 6.7 0.4 0.3 2.2 0.2 0.1
42 Ð NT 0.2 0.8 NT 0.2 0.8 NT ,0.1 0.2
45 3 2.7 ,0.1 0.2 3.9 0.4 0.4 0.7 0.1 0.1
47 5 40 8.5 1.3 33 7.2 1.4 3.4 0.7 0.6
49 7 67 9.9 26 58 12 23 3.7 1.4 1.4
Experiment 3
Ð 5 NT 0.2 6 0.1 0.1 NT 0.6 6 0.3 0.1 6 0.1 NT 0.3 6 0.2 0.1 6 0.1
27 Ð NT 0.6 2.0 NT 0.5 1.5 NT 0.2 0.3
32 5 NT 9.5 6 5.2c 1.4 6 0.5 NT 9.3 6 4.3c 1.3 6 0.4c NT 0.5 6 0.2c 0.2 6 0.1
a Naive B6 mice or mice primed i.p. with 107.9 EID50 of the PR8 (H1N1) influenza A virus were challenged i.n. 56, 42, or 27 days later with 106.8
EID50 of the serologically different HKx31 (H3N2) virus.
b The CD81 T cells were stained directly with the NPP tetramer, or stimulated with the NP366±372 or NS2114±121 peptides for 6 hr in the presence
of Brefeldin A, fixed, and stained for IFNg. The BAL cells were first adhered on plastic to remove macrophages, while the MLN and spleen
cells were enriched for the CD81 set to .75% purity by removing the CD41 T cells, B cells, and MHC class II1 cells using Dynabeads plus
the TIB120 and GK1.5 MAbs.
NT, not tested.
c Significantly greater (p , 0.001) than the values for the spleen. The data showing SD values is for five individual mice. The assays were done
as described in the Experimental Procedures.
virus (generally about 1:3000), but the difference is not as and 1.2%) and secondary (17% and 39%) responses,
respectively (Table 1, day 13 and day 69 and NPP1 andextraordinary as that found for LCMV (Butz and Bevan,
1998; Murali-Krishna et al., 1998). NP-IFNg1). The comparable values for day 7 after the
HKx31 challenge (Table 1, days 7, 63, and 49) were 0.3The peak frequencies detected at any stage (Table 1,
NS2-IFNg and MLN and spleen) for the minority and 0.5% (primary) and 9.9% and 26% (secondary). The
most surprising finding from these results is that theCD81IFNg1 H-2Kb1NS2114±121-specific set following i.n.
challenge with the HKx31 virus were 0.7% of (primary) prevalence of splenic CD81 T cells specific for the immu-
nodominant H-2Db1NP366±374 epitope is very high (Tableand 1.4% (secondary). Maximal counts for the immuno-
dominant NP366±374-specific CD81 T cells were recorded 1, day 69) long after the time that infectious virus would
normally have been eliminated from these mice (Allanin the MLN and spleen on day 13 of the primary (1.5%
Table 2. Immunodominance Hierarchies in the BAL
CD81 T Cells Staining (%)
Mouse Strain Day Priming and Challengea NP-IFNg NS2-IFNg
B6 9 HKx31 20.8 6 9.9 5.8 6 1.8c
HKx31 → PR8 69.4 6 19.5b 3.7 6 4.1c
12 HKx31 19.2 6 10.8 4.7 6 1.2c
HKx31 → PR8 79.1 6 1.5b 1.7 6 1.2b,c
mMtd 10 HKx31 24, 16 11, 4
HKx31 → HKx31 76, 82 10, 4
a The B6 mice were primed i.p. with the PR8 virus 1 month prior to challenge, while the mMT mice had been given the standard i.n. dose of
HKx31 8 months previously. Naive controls were challenged concurrently with the HKx31 virus. Groups of four or five mice were used in a
contemporary comparison with the B6 mice. The results for the mMT mice are for two naive and two primed individuals. The experimental
protocol and the peptide/BrefeldinA/IFNg assay system is described in the Experimental Procedures and in the legend to Table 1.
b Significantly different (p , 0.01) from the value for the primary response.
c Significantly different (p , 0.01) from the value for the immunodominant NP epitope.
d The response profiles for the MLN were also measured for the mMT mice. The values were NP: primary, 1.6, 1.9; secondary, 12.4, 15.4; NS2:
primary, 1.4, 1.5; secondary, 2.3, 1.5.
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Figure 4. Activation Phenotype of the CD81
T Cells in the BAL
The BAL population was obtained from sec-
ondarily challenged mice on day 13 and as-
sayed by flow cytometry for surface staining
with anti-CD8, NPP tetramer, and (A) CD44,
(B) CD62L, or (C) Vb8.3. The percentage of
BAL cells in the lymphocyte/lymphoblast
CD81 gate is shown for each of the quad-
rants.
et al., 1990). This effect was not apparent in prior LDA very great majority of the CD81NPP1 T cells were
CD44HiCD62LLo. This continued tobe true for spleencellsstudies (Tripp et al., 1995b) and the H3N2 influenza A
viruses cannot generally be isolated from mouse spleen from B6 mice primed 2 months previously with the PR8
virus (data not shown), confirming patterns determinedat any stage of the disease process (Eichelberger et al.,
1991). previously by LDA.
Previous flow cytometric analysis, LDA subsequentHowever, despite the fact that the H-2Db1NP366±374-
specific CD81 T cells were present at highest prevalence to FACS enrichment, and the generation of a range of
hybridoma T cell lines all indicated that the Vb8.3 Tin thespleen from day 7 after the HKx31challenge (Table
1, days 63 and 49) the antigen-driven increase in virus- cell receptor (TCR) chain is utilized at high frequency
(Deckhut et al., 1993) in the response to H-2Db1NP366±374.specific CD81 T cell numbers was initially more promi-
nent in the MLN (Table 1, day 47). This skewing of the Sequencing studies with the hybridomas indicated that
this response is polyclonal within the Vb8.31 set (Deck-host response to the MLN on day 5 was confirmed in
Expt. 3, where five individual mice were compared simul- hut et al., 1993). Direct staining for a spectrum of 16
different TCRVb and 3 TCRVa chains confirmed thattaneously (Table 1, day 32). The findings support the
idea that, although more mCTL are present in the resting Vb8.3 (Figure 4C) was selectively overexpressed on the
CD81NPP1 (cf. CD81NPP2) BAL population (data notspleen than in the MLN (Table 1, days 56, 42, and 27),
the drainage of antigen-presenting dendritic cells via shown). The only other TCR chain detected at enhanced
frequency on the CD81NPP1 lymphocytes recoveredafferent lymph triggers the secondary eCTL response
in the regional lymph node rather than the spleen (Table from mice with primary or secondary influenza pneumo-
nia was Vb4 (data not shown).1, day 32). This compartmentalization effect is also ap-
parent for the primary response (Table 1, day 5, Expt.
3, NP-IFNg), and for the secondary response to the mi- The Extent of Protection
The results overall (Figures 2 and 3 and Tables 1 andnority H-2Kb1NS2114±121 epitope (Table 1, day 32 and
NS2-IFNg). 2) illustrate very graphically the durability of established
CD81 T cell memory to the influenza A viruses and con-
firm earlier impressions of the limitations of the CD81 TPhenotype of the Virus-Specific T Cells
The BAL CD81NPP1 population showed the CD44Hi cell recall response as a sole protective mechanism
(Andrew et al., 1987; Doherty et al., 1989; Lawson etCD62LLo profile characteristic (Hou and Doherty, 1993;
Tripp et al., 1995a) of activated T cells (Figures 4A and al., 1994). The virus has at least 2±3 days to become
established in the respiratory tract before the conse-4B) from the time of initial localization to the virus-
infected lung (Figure 2) on day 5 (secondary) or day 7 quences of prior exposure are apparent (Figure 2 and
Table 1). Challenging HKx31 immune mice with the more(primary). Earlier cell-sorting experiments established
that this phenotype, which was maintained through- virulent PR8 virus led to a .100-fold reduction in lung
virus titers on day 6 when compared with primary PR8out the response (data not shown), is characteristic of
both the influenza virus±specific eCTL killer population infection (Table 3). However, though the immune mice
showed clear evidence of a secondary CD81 T cell re-and the mCTL set that can be expanded by LDA (Tripp
et al., 1995a). In fact, all of the lymphocytes (including sponse, in that greater numbers of CD81NPP1 T cells
were detected earlier in the BAL, all of the HKx31 im-the CD81 T cells, Figure 4A) recovered by BAL were
consistently CD44Hi. This may reflect that CD44 expres- mune and naive animals still succumbed to the PR8
infection. Influenza-specific CD81 T cells function insion is required to mediate lymphocyte extravasation
into sites of virus-induced inflammatory pathology (De- vivo via a perforin/granzyme or Fas-mediated cytotoxic
mechanism (Topham et al., 1997), so even though theGrendele et al., 1997). Different profiles were found for
the MLN and spleen, where approximately 20% (pri- virus-infected cells may be eliminated, the degree of
CTL-mediated damage to the respiratory epitheliummary) or 50% (secondary) of total CD81 T cells were
CD44Hi on day 7 after infection (data not shown). Simi- may not be survivable if the virus has disseminated too
extensively prior to the recall to eCTL function.larly, the staining profiles for the lymph node hom-
ing receptor (CD62L) partitioned the CD81 T cells in A difference between the PR8→HKx31 (Table 3) and
the HKx31→PR8 (Figures 2 and 3 and Table 1) challengelymphoid tissue into CD62LLo and CD62LHi subsets.
Both populations were also found in the BAL, though experiments was that the secondary response induced
in the BAL by the lower dose of the more virulent PR8the CD62LLo set was much more prevalent (Figure 4B).
However, at all times examined and in all tissues, the virus looked to be smaller in magnitude than that caused
Immunity
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Table 3. Early Control of Virus in the Secondary Response
% NPP1 CD81 T Cells in BAL Virus titer in Lung (log10 EID50)
PR8a Challenge Day 5 Day 6 Day 6
Primary 0.1 6 0.01 0.5 6 0.05 .6.5 6 0.0
Secondary 3.5 6 0.2 14.4 6 0.2 4.3 6 0.6
a The mice were primed i.n. with the HKx31 virus and then, together with naive controls (primary), challenged i.n. 2 months later with 104.0
EID50 of PR8 (secondary). Groups of five mice were assayed at each timepoint.
by HKx31. A further experiment with the HKx31→PR8 eCTL tend to be found only in the BAL of mice following
primary i.n. infection with the HKx31 virus (Allan et al.,model gave log10 EID50 lung titers of 5.7 6 0.1 and 5.9 6
0.6 on day 3 and 6.0 6 0.4 and 3.9 6 0.3 on day 5 1990) but are readily detected in the lymph nodes and
spleen of those given LCMV (Zinkernagel and Doherty,for the primary and secondary responses, respectively.
Again, the protective effect (Table 3) of established 1974; Lynch et al., 1989).
The clonal expansion of the virus-specific CD81 setCD81 T cell memory was delayed in onset, though it did
lead to a substantial (100-fold) early reduction of virus and the prevalence of mCTL that can be stained with
the tetrameric complexes is also much higher followingtiters in the lung. Other studies with Ig2/2 mMT mice have
also shown that the secondary CD81 T cell response primary infection with LCMV than with influenza. The
influenza-specific NPP1CD81 set is maintained at a levelto the relatively mild HKx31 virus is highly protective
(Topham and Doherty, 1998). of approximately 1:125 of the CD81 population in the
spleen and 1:300 in the MLN, after the acute phase
of the host response is terminated. The comparableDiscussion
calculation for LCMV-specific CD81 mCTLs is closer to
1:10. Again, the difference could be thought to reflectAnalysis of the BAL population with both the influenza
NPP tetramer and by staining NP366±374-specific T cells the extent of the clonal burst during the antigen-driven
phase of the host response (Hou et al., 1994). The caveatfor IFNg has provided rigorous, quantitative evidence
that very substantial numbers of virus-specific CD81 T to the interpretation that differential antigen concentra-
tion is the principal determinant of clonal burst size iscells are present in a nonlymphoid site of virus-induced
inflammatory process. Application of the same technol- that the frequencies demonstrated by tetramer staining
of enriched CD81 T cells from spleens of mice infectedogy established previously that the prevalence of virus-
specific CD81 T cells in the spleen during the course with an intracellular bacterium (Listeria monocytogenes)
that replicates in the lymphoid compartment are moreof primary LCMV infection is extremely high (Murali-
Krishna et al., 1998). At the peak of the response, more comparable to those found for influenza than for LCMV
(Busch et al., 1998). A further possibility is that at leastthan 50% of the splenic CD81 T cells are specific for
the two prominent LCMV epitopes recognized in H-2b some of the difference in magnitude for the responses
to LCMV (a natural mouse pathogen) and influenza virus,mice. By contrast, influenza-specific CD81 T cells are
found in much lower numbers in the regional lymph which does not normally infect mice, may reflect the
extent of the naive T cell repertoire and thus the magni-nodes and spleen (1%±2%), though the BAL CD81 T
cells show frequencies (20%±70%) comparable to those tude of the pCTL pool (Busch et al., 1998).
It is possible that, following the establishment of afound for the LCMV-specific set in lymphoid tissue. This
presumably reflects the differential distribution of anti- substantial mCTLpopulation, theprevalence of antigen-
presenting cells is a less critical determinant of the mag-gen in these virus infections.
While LCMV replicates extensively in the lymph nodes nitude of the secondary influenza-specific response in
the spleen. The HKx31 influenza A virus used for theand spleen (Buchmeier et al., 1980; Ahmed et al., 1987),
productive infection with the influenza A viruses is sub- majorityof the secondarychallenge experiments causes
little, if any, productive infection in lymphoid tissuestantially restricted to the lung (Eichelberger et al., 1991;
Hamilton-Easton and Eichelberger, 1995). The genera- (Hamilton-Easton and Eichelberger, 1995) and is gener-
ally eliminated from the lung by day 7 in Ig2/2 mMT micetion of infectious influenza A viruses depends on the
activity of a trypsin-like enzyme that functions to cleave with a primed CD81 T cell compartment (Topham and
Doherty, 1998). Perhaps, as suggested from earlier LDAthe precursor of the viral hemagglutin molecule (Walker
et al., 1992; Horimoto and Kawaoka, 1995). In mammals, experiments (Tripp et al., 1995c), the continued prolifera-
tion of highly activated T cells is (for a time) independentthe distribution of this enzyme seems to be largely re-
stricted to the respiratory epithelium. Much of the stimu- of antigen. However, little is known about the persis-
tence of antigen-presenting cells in this system (Ham-lus in the regional lymph nodes and spleen may result
from the migration of dendritic cells (Hamilton-Easton ilton-Easton and Eichelberger, 1995). An alternative
explanation for the massive numbers of CD81NPP1 lym-and Eichelberger, 1995) that are infected in the respira-
tory tract (Holt et al., 1993; McWilliam et al., 1997) and phocytes in the spleens of the secondarily challenged
mice could be that many of these are inflammatory Tsupport a full virus life cycle, with the exception that no
infectious progeny are produced. This means that, as cells that have exited the lung. Clearly, these insights
into the magnitudeof the influenza virus±specific CD81 Tthere should be no secondary spread in lymphoid tissue,
the antigen load in this site will be much lower for influ- cell response raise many questions that require further,
detailed analysis.enza than for LCMV. The consequence is that potent
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The current experiments with the influenza A viruses In general, the kinetics of the primary response deter-
leave no doubts concerning the durability and extent of mined by both staining for NPP and induction of IFNg
virus-specific CD81 T cell memory (Hou et al., 1994; Lau production with peptide reflect the results of previous
et al., 1994; Mullbacher, 1994; Ahmed and Gray, 1996; eCTL and LDA experiments (Doherty et al., 1978; Al-
Doherty et al., 1996). Mice primed 8 months previously louche et al., 1982; Askonas et al., 1982; Doherty et al.,
with the PR8 (H1N1) virus generate a very potent sec- 1996). The same is true for our earlier analyses of TCR
ondary CD81 T cell response following i.n. challenge and activation phenotypes (Deckhut et al., 1993; Tripp et
with the serologically distant HKx31 (H3N2) virus that al., 1995a). The availability of the NPP staining protocol
shares the NP366±374 epitope (Figure 2). There is no evi- clearly makes the analysis of cell-surface phenotypes
dence that influenza A virus persists in any sense in for the virus-specific CD81, which previously had to be
mammalian hosts, though the possibility that (as re- approached by LDA subsequent to FACS separation,
ported recently for LCMV) some viral genetic elements much more accessible. The major differences are that
may be copied back into the genome by retroviral re- the prevalence rates for mCTL in lymphoid tissue may
verse transcriptase (Klenerman et al., 1997) is yet to be 2- to 5-fold higher with the tetrameric-staining and
be investigated. This seems unlikely, as productive or peptide stimulation approaches than indicated by LDA,
nonproductive infection with the influenza A viruses in- we had no previous measure of eCTL numbers, and the
evitably leads to cell death. antigen-specific component of the secondary response
It is intriguing that mCTL from the lymph nodes and is much more massive than anyone could have pre-
spleen can be induced to secrete substantial amounts dicted. Earlier ideas about the size of both the eCTL
of IFNg within 6 hr of in vitro peptide restimulation (Table and mCTL sets (Doherty et al., 1996) need to be revised,
1), as shown previously for influenza-specific mCTL from and there is now a very clear picture of how greatly
human peripheral blood (Lalvani et al., 1997), but take skewed the eCTL/mCTL ratio is during the course of
3 days or more to localize in substantial numbers to the primary and secondary virus-specific T cell responses.
virus-infected respiratory tract. The delay in the recall Being able to stain the eCTL population directly also
of eCTL to the lung seems tobea function of the pathobi- showed that an immunodominance hierarchy character-
ology of the host response. The fact that the secondary istic of the primary response may be even more promi-
response appears to be initiated in the regional lymph nent in the inflammatory process following secondary
nodes raises the possibility that the mCTL must first be
i.n. challenge. A comparable difference between the na-
mobilized from the recirculating pool or be recruited to
ive and memory T cell responses was not seen for some-
the MLN from the much larger numbers found in resting
what similar studies with the L. monocytogenes model
spleen. The spleen is not subject to the gating mecha-
(Busch et al., 1998). The Listeria experiments used an
nism that facilitates the entry of naive CD62LHi T cells
homologous challenge system that could be compli-
into the lymph nodes via the high endothelial venules
cated by the effects of specific antibody to bacterial(Butcher and Picker, 1996) and concurrently excludes
surface components, and compared T cells at relativelythe CD81CD62LLo populations. These mCTLs are gener-
low frequency in thespleen rather than the site of pathol-ally thought to gain access to the lymph nodes via the
ogy. As predicted by the originators of the approachafferent lymph, after trafficking through somatic tissues
(Altman et al., 1996; McHeyzer-Williams et al., 1996),(Mackay et al., 1992).
many new experimental possibilities, questions, and de-Enlargement of the regional lymph nodes is an early
bates are being opened by the availability of the tetramerevent in these respiratory virus infections (Doherty et al.,
technology.1992). Some of the massive, nonselective lymphocyte
recruitment (Allan et al., 1990) that occurs may reflect
Experimental Proceduresthe direct influence of cytokines, such as the type 1
interferons (Gresser et al., 1981; Korngold et al., 1983;
Virus Infection and MiceTough et al., 1996). Perhaps these cytokines constitute
The C57BL/6J (B6) female mice were anesthetized with avertin
(or act to trigger) a damage signal (Matzinger, 1994) (2,2,2-tribromoethanol) and then infected i.n. with varying egg infec-
inducing the expression of endothelial receptors (Butcher tious doses (log10 EID50) of different influenza viruses (Allan et al.,
and Picker, 1996) that facilitate the direct extravasation 1990, 1993). Most experiments were done using a nonlethal chal-
lenge (106.8 EID50) with the A/HKx31 (HKx31, H3N2) influenza A virus,of any recirculating T cells (including the CD62LLo set)
a regime that was also used to prime for long-term memory. Miceinto the lymph node. It is known that CD44-hyaluronate
given 104 EID50 of the A/PR8/34 (PR8, H1N1) influenza A virus i.n.interactions are important for the migration of superanti-
generally succumbed to the infection, while the majority survivedgen-stimulated T cells to sites of inflammatory pathol-
respiratory challenge with 10-fold less virus. Administering 107.9 EID50ogy (DeGrendele et al., 1997). Previous LDA analysis of PR8 i.p. caused no obvious symptoms and was also used to
(Tripp et al., 1995a) indicates that resting influenza-spe- establish memory. Some controls were given a 105.6 i.n. dose of
cific mCTLs are constitutively CD44Hi. The other possibil- the noncross-reactive B/Hong Kong/73 (B/HK) influenza B virus. All
immune mice were held for at least 1 month prior to secondaryity is that the initiation of the whole secondary response
challenge.in this localized virus infection is dependent on the rela-
tively small population of resting mCTL detected in the
Tissue Sampling and Treatmentregional lymph nodes. If this is the case, the kinetic
Inflammatory cells were obtained from anesthetized infected micefactors determining the recall rate for eCTLs to the lung
by BAL. The BAL cells were first absorbed on plastic petri dishes
will be determined by the mCTL numbers in the MLN (Falcon, Lincoln Park,NJ) for 60 min at 378C to remove macrophages
and the time taken for the antigen-presenting dendritic (Allan et al., 1990). In some experiments, the lungs were frozen and
cells to exit the virus-infected respiratory tract via affer- later homogenized for virus isolation in embryonated hen's eggs
(Allan et al., 1990). Single cell suspensions were prepared froment lymph (McWilliam et al., 1997).
Immunity
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spleen and MLN, and erythrocytes were lysed. The MLN and spleen maintained in the laboratory of Marcy Blackman. Public Health Ser-
vicegrants AI29579, AI38359, AI37597, and CA21765, and the Ameri-populations were enriched for CD81 T cells (Hou et al., 1994) by
treatment with MAbs to CD4 (GK1.5) and MHC class II (TIB120), can Lebanese Syrian Associated Charities supported these experi-
ments. G. T. B. is a C. J. Martin fellow of the Australian Nationalfollowed by sheep anti-mouse and sheep anti-rat Dynabeads (Dynal
A. S, Oslo, Norway). The final preparations from the MLN and spleen Health and Medical Research Council (Reg. Key. 977 309).
contained 85%±95% and 75%±85% CD81 T cells, respectively.
Received April 9, 1998; revised May 8, 1998.
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